• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在微生理系统(MPS)中培养大鼠或人肝细胞以鉴定肝毒性的特征。

Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.

作者信息

Chang Shih-Yu, Voellinger Jenna L, Van Ness Kirk P, Chapron Brian, Shaffer Rachel M, Neumann Thomas, White Collin C, Kavanagh Terrance J, Kelly Edward J, Eaton David L

机构信息

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.

Department of Pharmaceutics, University of Washington, Seattle, WA 98195, USA.

出版信息

Toxicol In Vitro. 2017 Apr;40:170-183. doi: 10.1016/j.tiv.2017.01.007. Epub 2017 Jan 13.

DOI:10.1016/j.tiv.2017.01.007
PMID:28089783
Abstract

The liver is the main site for drug and xenobiotics metabolism, including inactivation or bioactivation. In order to improve the predictability of drug safety and efficacy in clinical development, and to facilitate the evaluation of the potential human health effects from exposure to environmental contaminants, there is a critical need to accurately model human organ systems such as the liver in vitro. We are developing a microphysiological system (MPS) based on a new commercial microfluidic platform (Nortis, Inc.) that can utilize primary liver cells from multiple species (e.g., rat and human). Compared to conventional monolayer cell culture, which typically survives for 5-7days or less, primary rat or human hepatocytes in an MPS exhibited higher viability and improved hepatic functions, such as albumin production, expression of hepatocyte marker HNF4α and canaliculi structure, for up to 14days. Additionally, induction of Cytochrome P450 (CYP) 1A and 3A4 in cryopreserved human hepatocytes was observed in the MPS. The acute cytotoxicity of the potent hepatotoxic and hepatocarcinogen, aflatoxin B, was evaluated in human hepatocytes cultured in an MPS, demonstrating the utility of this model for acute hepatotoxicity assessment. These results indicate that MPS-cultured hepatocytes provide a promising approach for evaluating chemical toxicity in vitro.

摘要

肝脏是药物和异生素代谢的主要场所,包括失活或生物活化。为了提高临床开发中药物安全性和有效性的可预测性,并促进对接触环境污染物可能对人类健康产生的影响进行评估,迫切需要在体外准确模拟人体器官系统,如肝脏。我们正在基于一种新的商业微流控平台(Nortis公司)开发一种微生理系统(MPS),该平台可以利用多种物种(如大鼠和人类)的原代肝细胞。与通常存活5-7天或更短时间的传统单层细胞培养相比,MPS中的原代大鼠或人类肝细胞表现出更高的活力和改善的肝功能,如白蛋白产生、肝细胞标志物HNF4α的表达和胆小管结构,长达14天。此外,在MPS中观察到冷冻保存的人肝细胞中细胞色素P450(CYP)1A和3A4的诱导。在MPS中培养的人肝细胞中评估了强效肝毒性和肝癌致癌物黄曲霉毒素B的急性细胞毒性,证明了该模型在急性肝毒性评估中的实用性。这些结果表明,MPS培养的肝细胞为体外评估化学毒性提供了一种有前景的方法。

相似文献

1
Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.在微生理系统(MPS)中培养大鼠或人肝细胞以鉴定肝毒性的特征。
Toxicol In Vitro. 2017 Apr;40:170-183. doi: 10.1016/j.tiv.2017.01.007. Epub 2017 Jan 13.
2
Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.描述使用肝微生理系统测定药物毒性、代谢和积累的可重复性。
Clin Transl Sci. 2021 May;14(3):1049-1061. doi: 10.1111/cts.12969. Epub 2021 Apr 3.
3
In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.在来自多个供体的人肝细胞中对肝毒性药物进行体外评估:鉴定 P450 活性作为药物性肝损伤的潜在风险因素。
Chem Biol Interact. 2016 Aug 5;255:12-22. doi: 10.1016/j.cbi.2015.12.013. Epub 2015 Dec 21.
4
Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.冷冻保存的人肝细胞作为细胞色素P450诱导研究的替代体外模型。
In Vitro Cell Dev Biol Anim. 2003 Jul-Aug;39(7):283-7. doi: 10.1290/1543-706X(2003)039<0283:CHHAAI>2.0.CO;2.
5
Sensitivities of gel entrapped hepatocytes in hollow fibers to hepatotoxic drug.中空纤维中凝胶包封的肝细胞对肝毒性药物的敏感性。
Toxicol Lett. 2006 Sep 30;166(1):19-26. doi: 10.1016/j.toxlet.2006.05.008. Epub 2006 May 17.
6
Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.冷冻保存的人肝细胞:药物代谢酶活性的表征及其在肝毒性、代谢稳定性和药物相互作用潜力高通量筛选试验中的应用。
Chem Biol Interact. 1999 Jun 1;121(1):17-35. doi: 10.1016/s0009-2797(99)00088-5.
7
Definition of metabolism-dependent xenobiotic toxicity with co-cultures of human hepatocytes and mouse 3T3 fibroblasts in the novel integrated discrete multiple organ co-culture (IdMOC) experimental system: results with model toxicants aflatoxin B1, cyclophosphamide and tamoxifen.新型整合离散多器官共培养(IdMOC)实验系统中人肝细胞和小鼠 3T3 成纤维细胞共培养物中代谢依赖性外源化学物毒性的定义:以黄曲霉毒素 B1、环磷酰胺和他莫昔芬为模型毒物的结果。
Chem Biol Interact. 2012 Jul 30;199(1):1-8. doi: 10.1016/j.cbi.2012.05.003. Epub 2012 May 26.
8
Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies.人HepaRG肝细胞的长期功能稳定性及其在慢性毒性和遗传毒性研究中的应用。
Drug Metab Dispos. 2008 Jun;36(6):1111-8. doi: 10.1124/dmd.107.019901. Epub 2008 Mar 17.
9
Automated triplexed hepatocyte-based viability and CYP1A and -3A induction assays.基于自动化三重肝细胞的活力以及CYP1A和CYP3A诱导分析
J Biomol Screen. 2011 Sep;16(8):895-902. doi: 10.1177/1087057111411482. Epub 2011 Jun 21.
10
A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.用于提高临床相关药物诱导肝毒性预测能力的长期三维肝脏共培养系统。
Toxicol Appl Pharmacol. 2013 Apr 1;268(1):1-16. doi: 10.1016/j.taap.2013.01.012. Epub 2013 Jan 23.

引用本文的文献

1
Development of an Easy-To-Use Microfluidic System to Assess Dynamic Exposure to Mycotoxins in 3D Culture Models: Evaluation of Ochratoxin A and Patulin Cytotoxicity.开发一种易于使用的微流控系统以评估三维培养模型中霉菌毒素的动态暴露:赭曲霉毒素A和展青霉素细胞毒性的评估
Foods. 2024 Dec 23;13(24):4167. doi: 10.3390/foods13244167.
2
Isolation and Cryopreservation of Primary Macaque Hepatocytes.原代食蟹猴肝细胞的分离和冻存。
Curr Protoc. 2024 Sep;4(9):e70015. doi: 10.1002/cpz1.70015.
3
Regenerative human liver organoids (HLOs) in a pillar/perfusion plate for hepatotoxicity assays.
用于肝毒性检测的柱形/灌注板中的再生人肝类器官(HLOs)。
bioRxiv. 2024 Nov 3:2024.03.25.586638. doi: 10.1101/2024.03.25.586638.
4
The Growing Importance of Three-Dimensional Models and Microphysiological Systems in the Assessment of Mycotoxin Toxicity.三维模型和微生理系统在评估霉菌毒素毒性方面的重要性日益增加。
Toxins (Basel). 2023 Jun 29;15(7):422. doi: 10.3390/toxins15070422.
5
Design, Simulation, and Evaluation of Polymer-Based Microfluidic Devices via Computational Fluid Dynamics and Cell Culture "On-Chip".基于计算流体力学和细胞培养的聚合物微流控器件的设计、模拟与评估。
Biosensors (Basel). 2023 Jul 22;13(7):754. doi: 10.3390/bios13070754.
6
A quantitative meta-analysis comparing cell models in perfused organ on a chip with static cell cultures.定量荟萃分析比较在灌注器官芯片中的细胞模型与静态细胞培养。
Sci Rep. 2023 May 22;13(1):8233. doi: 10.1038/s41598-023-35043-5.
7
A comprehensive overview of advanced dynamic intestinal and hepatic cell culture models.高级动态肠和肝细胞培养模型的全面概述。
Tissue Barriers. 2024 Jan 2;12(1):2163820. doi: 10.1080/21688370.2022.2163820. Epub 2023 Jan 21.
8
Gutsy science: In vitro systems of the human intestine to model oral drug disposition.勇敢的科学:模拟口服药物处置的人体肠道体外系统。
Pharmacol Ther. 2022 Feb;230:107962. doi: 10.1016/j.pharmthera.2021.107962. Epub 2021 Aug 31.
9
Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing.肾脏类器官和微生理肾脏芯片模型以加速药物研发并减少动物实验。
Front Pharmacol. 2021 Jul 26;12:695920. doi: 10.3389/fphar.2021.695920. eCollection 2021.
10
African Herbal Medicines: Adverse Effects and Cytotoxic Potentials with Different Therapeutic Applications.非洲草药:不同治疗应用的不良反应和细胞毒性潜力。
Int J Environ Res Public Health. 2021 Jun 2;18(11):5988. doi: 10.3390/ijerph18115988.